Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_assertion type Assertion NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_head.
- NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_assertion description "[As with Japanese HCV patients with genotypes 1b/II-2b/IV, higher hepatic IFNAR mRNA expression in the United States with predominant genotypes 1a/I and 1b/II appears to correlate with response to IFN therapy and a low HCV RNA titer but not with the total HAI or its components.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_provenance.
- NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_assertion evidence source_evidence_literature NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_provenance.
- NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_assertion SIO_000772 10505743 NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_provenance.
- NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_assertion wasDerivedFrom befree-20140225 NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_provenance.
- NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_assertion wasGeneratedBy ECO_0000203 NP677620.RADzpVakHVpJWe_zTIdZu6hOdwTfPEHvZlrqsK7MeR9Ag130_provenance.